Sandwich, United Kingdom

Michael Paul Fitzgerald

This inventor holds 2 USPTO granted patents. Top assignee: Pfizer Corporation. Active years: 2003-2008.


Average Co-Inventor Count = 3.1

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • County of Kent, GB (2003)
  • Sandwich, GB (2008)

Company Filing History:


Years Active: 2003-2008

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Michael Paul Fitzgerald: Innovator in Pharmaceutical Chemistry

Introduction

Michael Paul Fitzgerald is a notable inventor based in Sandwich, GB. He has made significant contributions to the field of pharmaceutical chemistry, holding 2 patents that showcase his innovative approach to complex chemical processes.

Latest Patents

Fitzgerald's latest patents include a process for controlling the hydrate mix of a compound. This invention relates to a method for managing the hydrate mix of a compound capable of forming various hydration forms with differing stability. It also addresses the dissolution of the compound to create a solution that, when frozen below the eutectic point, results in a eutectic mixture. Another significant patent involves the preparation of (7-(3-carboxyphenyl)-4-chloroisoquinolin-1-yl)guanidine, including intermediates and new formulations suitable for pharmaceutical use.

Career Highlights

Michael Paul Fitzgerald is currently associated with Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to focus on innovative solutions that enhance drug formulation and stability.

Collaborations

Fitzgerald has collaborated with esteemed colleagues such as Julie Ann Macrae and Anne Bruckner, contributing to a dynamic research environment that fosters innovation.

Conclusion

Michael Paul Fitzgerald's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the industry. His work continues to influence the development of effective pharmaceutical solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…